During the past decade, Hospital Universitario Rio Hortega conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 13 clinical trials were completed, i.e. on average, 18.1% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 7 clinical trials were completed. i.e. 15.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Rio Hortega" #1 sponsor was "Hospital del Río Hortega" with 11 trials, followed by "PETHEMA Foundation" with 5 trials sponsored, "Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea" with 4 trials sponsored, "Grupo Español de Rehabilitación Multimodal" with 4 trials sponsored and "Fundacion SEIMC-GESIDA" with 4 trials sponsored. Other sponsors include 81 different institutions and companies that sponsored additional 79 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Rio Hortega" #1 collaborator was "Hospital del Río Hortega" with 3 trials as a collaborator, "University of Valladolid" with 3 trials as a collaborator, "Asociación Científica Pulmón y Ventilación Mecánica" with 2 trials as a collaborator, "Celgene" with 2 trials as a collaborator and "Citospin" with 2 trials as a collaborator. Other collaborators include 60 different institutions and companies that were collaborators in the rest 64 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Rio Hortega" are "Critical Illness" (3 trials), "Geographic Atrophy" (3 trials), "Macular Degeneration" (3 trials), "Perioperative Care" (3 trials) and "Postoperative Complications" (3 trials). Many other conditions were trialed in "Hospital Universitario Rio Hortega" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Rio Hortega" are "Drug" (49 trials), "Other" (22 trials), "Procedure" (13 trials), "Device" (12 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Ara-C" (2 trials), "Dexamethasone" (2 trials), "Methylprednisolone" (2 trials) and "Sham Procedure" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Rio Hortega" are 104 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Rio Hortega". undefined are not yet recruiting, 24 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 60 completed trials in Hospital Universitario Rio Hortega, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Rio Hortega, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 18 trials that are defined as “Not Applicable".